ESSA Pharma announces $80M cash distribution ($1.91/share) to shareholders; record date Aug 19, payment Aug 22

ESSA Pharma Inc.

Court approved capital reduction; board authorized US$80M distribution to shareholders.
Distribution paid Aug 22 to holders of record Aug 19; precedes Sep 10 special meeting for Xeno transaction.
Total expected per share ~US$1.91, excluding contingent value rights.
Business combination with XenoTherapeutics: Xeno to acquire all ESSA shares.

item 8.01item 9.01

This headline and bullets were generated automatically by deepseek-v4-flash:cloud@v2 from the public filing. Read the source on SEC.gov before relying on any specific claim. Not investment advice. See methodology for how this pipeline works.